Li 2016a.
Study characteristics | |||
Patient Sampling | In this retrospective study, 95 patients with chronic hepatitis B who were diagnosed with a small HCC (≤ 2 cm) or a cirrhotic nodule between July 2014 and September 2015 were involved. The patient inclusion criteria were as follows: (1) ElastPQ measurements were performed on lesion and background liver, (2) lesion nature was confirmed by pathology or at least 2 of the three contrast‐enhanced imaging modalities (CEUS, CECT, or CEMRI), and (3) the cirrhotic nodule had follow‐up for more than 6 months with no malignancy changes observed in physical examinations. Age range: 38‐61. Males 87% |
||
Patient characteristics and setting | |||
Index tests | AFP: threshold pre‐specified: cut‐off ≤ 20 ng/mL | ||
Target condition and reference standard(s) | In the small HCC group, 53 patients were included, with 26 patients confirmed by pathology and 27 patients confirmed by at least 2 of the 3 contrast enhanced imaging modalities (CEUS, CECT, CEMRI). Case‐control study |
||
Flow and timing | Reference standard: pathology, contrast‐enhanced ultrasound, contrast‐enhanced CT, contrast‐enhanced MRI No data on interval between index test and reference standard |
||
Comparative | |||
Notes | The authors declared no conflicts of interest. | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | No | ||
Was a case‐control design avoided? | No | ||
Did the study avoid inappropriate exclusions? | No | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | High | ||
DOMAIN 2: Index Test (AFP) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | No | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Could the conduct or interpretation of the index test have introduced bias? | High risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 2: Index Test (US+AFP) | |||
DOMAIN 2: Index Test (US) | |||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Low risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | No | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | High risk |